1. Kim, Minhee, Park, Jin Hee, Go, Miyeon, Shim, Hyunbo, Lee, Soo Young. 2024. RUFY4 deletion prevents pathological bone loss by blocking endo-lysosomal trafficking of osteoclasts. In Bone research, 12, 29. doi:10.1038/s41413-024-00326-8. https://pubmed.ncbi.nlm.nih.gov/38744829/
2. Terawaki, Seigo, Camosseto, Voahirana, Pierre, Philippe, Gatti, Evelina. . RUFY4: Immunity piggybacking on autophagy? In Autophagy, 12, 598-600. doi:10.1080/15548627.2015.1136772. https://pubmed.ncbi.nlm.nih.gov/26760128/
3. Miao, Daojia, Shi, Jian, Xiong, Zhiyong, Yang, Hongmei, Zhang, Xiaoping. 2022. As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner. In Cancer cell international, 22, 66. doi:10.1186/s12935-022-02480-7. https://pubmed.ncbi.nlm.nih.gov/35135552/